Age differences in eicosanoid production of mouse splenocytes: effects on mitogen-induced T-cell proliferation.
In order to determine the contribution of suppressive factors secreted from macrophages to the age-associated decline in T-cell mediated mitogenic responses, experiments were conducted to characterize eicosanoid and H2O2 production, total cellular fatty acid, and vitamin E composition of splenocytes isolated from young (4 mo) and old (24 mo) C57BL/6NIA mice. An age-related increase was observed in Ca++ ionophore A23187-stimulated ex-vivo production of prostaglandin (PG) E2, leukotriene (LT) B4, and LTC4 (p < .01), and in concanavalin A (ConA)-stimulated PGE2 production (p < .01). No age-related difference was observed in ex-vivo production of 12- and 15-hydroxyeicosatetranoic acid (HETE). The age-related increase in PGE2 production was also observed in lipopolysaccharide-stimulated peritoneal macrophages of C57BL/6NIA mice and ConA and phytohemagglutinin (PHA)-stimulated splenocytes isolated from DBA mice. Inhibition of cyclooxygenase with indomethacin resulted in increased ConA-stimulated proliferation of splenocytes from old mice (p < .01), while 5-lipoxygenase inhibition did not have an effect on mitogen induced proliferation. Furthermore, PGE2 addition to purified splenic T-cells decreased their proliferation. No age-related differences were observed in total cellular fatty acid composition, vitamin E level, or ex-vivo production of H2O2 from splenocytes stimulated with 10 or 100 ng phorbol myristate acetate (PMA). These data indicate that aging is associated with increased production of PG and LT from activated splenocytes. Inhibition of PGE2 but not LT production enhances mitogenic responses of old mice, suggesting a contributory role for PGE2 in the age-associated decline of T-cell responsiveness to polyclonal mitogens.
Hayek
M G
MG
Nutritional Immunology Laboratory, Tufts University, Boston.
Meydani
S N
SN
Meydani
M
M
Blumberg
J B
JB
D000375:Aging / Q000276:immunology* / Q000378:metabolism; D000818:Animals; D000001:Calcimycin / Q000494:pharmacology; D015232:Dinoprostone / Q000378:metabolism; D015777:Eicosanoids / Q000096:biosynthesis*; D005227:Fatty Acids / Q000032:analysis; D006861:Hydrogen Peroxide / Q000378:metabolism; D008213:Lymphocyte Activation / Q000187:drug effects; D017737:Macrophages, Peritoneal / Q000276:immunology / Q000378:metabolism; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008811:Mice, Inbred DBA; D008934:Mitogens / Q000494:pharmacology; D013047:Specific Pathogen-Free Organisms; D013154:Spleen / Q000166:cytology / Q000276:immunology / Q000378:metabolism*; D013601:T-Lymphocytes / Q000276:immunology*; D014810:Vitamin E / Q000032:analysis
D015777:Eicosanoids; D005227:Fatty Acids; D008934:Mitogens; D014810:Vitamin E; D000001:Calcimycin; D006861:Hydrogen Peroxide; D015232:Dinoprostone